New combo therapy aims to tame rare blood vessel diseases
NCT ID NCT00647166
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 24 times
Summary
This study tested whether adding azathioprine to standard corticosteroids helps people with newly diagnosed microscopic polyangiitis, polyarteritis nodosa, or eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) who have no poor prognosis factors. The goal was to see if the combination leads to higher remission and fewer relapses over 24 months without increasing side effects. 114 adults participated in this Phase 3 trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MPA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hopital Cochin Pôle de Médecine UF Médecine Interne
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.